JP2015514068A5 - - Google Patents

Download PDF

Info

Publication number
JP2015514068A5
JP2015514068A5 JP2015501002A JP2015501002A JP2015514068A5 JP 2015514068 A5 JP2015514068 A5 JP 2015514068A5 JP 2015501002 A JP2015501002 A JP 2015501002A JP 2015501002 A JP2015501002 A JP 2015501002A JP 2015514068 A5 JP2015514068 A5 JP 2015514068A5
Authority
JP
Japan
Prior art keywords
antibody
antigen
binding fragment
rsv
mpv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015501002A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015514068A (ja
JP6445423B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2013/000627 external-priority patent/WO2013140247A1/en
Publication of JP2015514068A publication Critical patent/JP2015514068A/ja
Publication of JP2015514068A5 publication Critical patent/JP2015514068A5/ja
Application granted granted Critical
Publication of JP6445423B2 publication Critical patent/JP6445423B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015501002A 2012-03-20 2013-03-14 Rsv、mpvおよびpvmを中和する抗体およびその利用 Active JP6445423B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261613197P 2012-03-20 2012-03-20
US61/613,197 2012-03-20
US201261655310P 2012-06-04 2012-06-04
US61/655,310 2012-06-04
PCT/IB2013/000627 WO2013140247A1 (en) 2012-03-20 2013-03-14 Antibodies that neutralize rsv, mpv and pvm and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018224174A Division JP6722264B2 (ja) 2012-03-20 2018-11-29 Rsv、mpvおよびpvmを中和する抗体およびその利用

Publications (3)

Publication Number Publication Date
JP2015514068A JP2015514068A (ja) 2015-05-18
JP2015514068A5 true JP2015514068A5 (https=) 2018-11-01
JP6445423B2 JP6445423B2 (ja) 2018-12-26

Family

ID=48471031

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2015501002A Active JP6445423B2 (ja) 2012-03-20 2013-03-14 Rsv、mpvおよびpvmを中和する抗体およびその利用
JP2018224174A Expired - Fee Related JP6722264B2 (ja) 2012-03-20 2018-11-29 Rsv、mpvおよびpvmを中和する抗体およびその利用
JP2020106004A Expired - Fee Related JP7069251B2 (ja) 2012-03-20 2020-06-19 Rsv、mpvおよびpvmを中和する抗体およびその利用
JP2022076023A Pending JP2022132244A (ja) 2012-03-20 2022-05-02 Rsv、mpvおよびpvmを中和する抗体およびその利用

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2018224174A Expired - Fee Related JP6722264B2 (ja) 2012-03-20 2018-11-29 Rsv、mpvおよびpvmを中和する抗体およびその利用
JP2020106004A Expired - Fee Related JP7069251B2 (ja) 2012-03-20 2020-06-19 Rsv、mpvおよびpvmを中和する抗体およびその利用
JP2022076023A Pending JP2022132244A (ja) 2012-03-20 2022-05-02 Rsv、mpvおよびpvmを中和する抗体およびその利用

Country Status (16)

Country Link
US (4) US9498531B2 (https=)
EP (1) EP2828293B1 (https=)
JP (4) JP6445423B2 (https=)
KR (1) KR102149069B1 (https=)
CN (2) CN104350069B (https=)
AU (1) AU2013237087B2 (https=)
BR (1) BR112014023063A2 (https=)
CA (1) CA2865856C (https=)
DK (1) DK2828293T3 (https=)
EA (1) EA030319B1 (https=)
ES (1) ES2657470T3 (https=)
IL (1) IL234710A (https=)
IN (1) IN2014DN07299A (https=)
NZ (1) NZ630920A (https=)
PL (1) PL2828293T3 (https=)
WO (1) WO2013140247A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104350069B (zh) 2012-03-20 2017-12-01 胡默波斯生物医学公司 中和rsv、mpv和pvm的抗体和其应用
MX2015009819A (es) 2013-01-28 2015-10-29 Evec Inc Anticuerpo humano especifico a metapneumovirus humano, o fragmento de union al antigeno del mismo.
TWI659968B (zh) 2013-03-14 2019-05-21 再生元醫藥公司 針對呼吸道融合病毒f蛋白質的人類抗體及其使用方法
WO2020160171A1 (en) * 2019-01-29 2020-08-06 Sanford Burnham Prebys Medical Discovery Institute Topically formulated antibody compositions for reducing pathogen transmission and methods of using same
WO2020236974A1 (en) 2019-05-21 2020-11-26 University Of Georgia Research Foundation, Inc. Antibodies that bind human metapneumovirus fusion protein and their use
CN117136197A (zh) * 2021-02-09 2023-11-28 胡默波斯生物医学公司 抗呼吸道合胞病毒、人偏肺病毒和小鼠肺炎病毒的抗体和其使用方法
JP2024507948A (ja) * 2021-02-26 2024-02-21 フレッド ハッチンソン キャンサー センター 呼吸器ウイルス感染症に対する防御抗体
CN115466326B (zh) * 2021-06-11 2024-06-04 中国科学院微生物研究所 一种呼吸道合胞病毒的人源单克隆抗体及其应用
EP4446339A4 (en) * 2021-12-06 2026-01-14 Univ Xiamen ANTIBODIES TO RECOGNIZE A PRE-F PROTEIN OF RSV AND ITS USAGE
WO2025015321A1 (en) * 2023-07-13 2025-01-16 Vir Biotechnology, Inc. Broadly neutralizing antibodies against rsv and mpv paramyxoviruses

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154600B (nl) 1971-02-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen.
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3766162A (en) 1971-08-24 1973-10-16 Hoffmann La Roche Barbituric acid antigens and antibodies specific therefor
US4179337A (en) 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
US4233402A (en) 1978-04-05 1980-11-11 Syva Company Reagents and method employing channeling
JPS5896026A (ja) 1981-10-30 1983-06-07 Nippon Chemiphar Co Ltd 新規ウロキナ−ゼ誘導体およびその製造法ならびにそれを含有する血栓溶解剤
DE3380726D1 (en) 1982-06-24 1989-11-23 Japan Chem Res Long-acting composition
US4766106A (en) 1985-06-26 1988-08-23 Cetus Corporation Solubilization of proteins for pharmaceutical compositions using polymer conjugation
US4676980A (en) 1985-09-23 1987-06-30 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Target specific cross-linked heteroantibodies
US4831175A (en) 1986-09-05 1989-05-16 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Backbone polysubstituted chelates for forming a metal chelate-protein conjugate
US5595721A (en) 1993-09-16 1997-01-21 Coulter Pharmaceutical, Inc. Radioimmunotherapy of lymphoma using anti-CD20
US20020102208A1 (en) 1999-03-01 2002-08-01 Paul Chinn Radiolabeling kit and binding assay
MY133346A (en) 1999-03-01 2007-11-30 Biogen Inc Kit for radiolabeling ligands with yttrium-90
US20040096451A1 (en) 2002-07-25 2004-05-20 Young James F. Methods of treating and preventing RSV, hMPV, and PIV using anti-RSV, anti-hMPV, and anti-PIV antibodies
KR20040002853A (ko) 2001-01-19 2004-01-07 비로노바티브 비.브이. 감응성 포유류에서 호흡계 질환을 유발하는 바이러스
AU2003210060B2 (en) 2002-03-22 2010-02-25 Aprogen, Inc. Humanized antibody and process for preparing same
AU2004215125B2 (en) 2003-02-26 2011-01-06 Institute For Research In Biomedicine Monoclonal antibody production by EBV transformation of B cells
WO2004092207A2 (en) * 2003-04-16 2004-10-28 Algonomics N.V. Respiratory syncytial virus (rsv) peptides
EP1473037A1 (en) 2003-05-02 2004-11-03 Vironovative B.V. Treatment of hPMV infections with Ribavirin
JP4976376B2 (ja) * 2005-04-08 2012-07-18 メディミューン,エルエルシー 哺乳動物メタニューモウイルスに対する抗体
EP1997830A1 (en) * 2007-06-01 2008-12-03 AIMM Therapeutics B.V. RSV specific binding molecules and means for producing them
PL2350128T3 (pl) 2008-10-22 2015-03-31 Inst Res Biomedicine Sposoby wytwarzania przeciwciał z komórek plazmatycznych
EP2445527A2 (en) * 2009-06-24 2012-05-02 ID Biomedical Corporation of Quebec Vaccine
JP5762408B2 (ja) * 2009-08-13 2015-08-12 クルセル ホランド ベー ヴェー ヒト呼吸器合胞体ウイルス(rsv)に対する抗体および使用方法
BR112012031638B1 (pt) * 2010-07-09 2021-01-12 Janssen Vaccines & Prevention B.V. anticorpo anti-rsv ou fragmento de ligação de antígeno do mesmo, anticorpo multivalente, composição farmacêutica, uso de anticorpo ou fragmento de ligação de antígeno, método de detectar infecção por rsv, e, ácido nucleico isolado
CN104350069B (zh) * 2012-03-20 2017-12-01 胡默波斯生物医学公司 中和rsv、mpv和pvm的抗体和其应用

Similar Documents

Publication Publication Date Title
JP2015514068A5 (https=)
HRP20201975T1 (hr) Neutralizirajuća protutijela anti-influenca a virusa i njihova uporaba
JP2011528902A5 (https=)
RU2016100892A (ru) Антитела против tweakr и их применение
JP2018535650A5 (https=)
RU2011105062A (ru) Нейтрализующие антитела против вируса гриппа а и их использование
JP2015511817A5 (https=)
JP2010516229A5 (https=)
JP2020500538A5 (https=)
JP2018536393A5 (https=)
RU2009129403A (ru) Антитела, нейтрализующие цитомегаловирус человека, и их применение
FI3487882T3 (fi) Gprc5d-vasta-aineita, bispesifisiä antigeeniä sitovia molekyylejä, jotka sitovat gprc5d:tä ja cd3:a, sekä niiden käyttötapoja
JP2014526898A5 (https=)
JP2012010714A5 (https=)
JP2019535763A5 (https=)
JP2014511179A5 (https=)
JP2015503909A5 (https=)
RU2020124153A (ru) Гуманизированные антитела к cd19 человека и способы их применения
JP2018521638A5 (https=)
JP2016529229A5 (https=)
JP2017530722A5 (https=)
JP2010521147A5 (https=)
JP2012504955A5 (https=)
JP2013538057A5 (https=)
RU2016137110A (ru) Антитела к компоненту комплемента с5